| Literature DB >> 28688288 |
Shan Li1, Yanyi Xu1, Jiayi Yu1, Matthew L Becker2.
Abstract
Additive manufacturing has the potential to revolutionize regenerative medicine, but the harsh thermal or photochemical conditions during the 3D printing process limit the inclusion of drugs, growth factors and other biologics within the resulting scaffolds. Functionalization strategies that enable specific placement of bioactive species on the surface of 3D printed structures following the printing process afford a promising approach to sidestep the harsh conditions and incorporate these valuable bioactive molecules with precise control over concentration. Herein, resorbable polymer scaffolds were prepared from propargyl functionalized L-phenylalanine-based poly(ester urea)s (PEUs). Osteogenic growth peptide (OGP) or bone morphogenic protein-2 (BMP-2) peptides were immobilized on PEU scaffolds through surface available propargyl groups via copper-catalyzed azide alkyne cycloaddition (CuAAC) post 3D printing. The presence of either OGP or BMP-2 significantly enhanced hMSCs osteogenic differentiation compared to unfunctionalized scaffolds.Entities:
Keywords: 3D printing; BMP-2; OGP; Osteogenic differentiation; Poly(ester urea); hMSCs
Mesh:
Substances:
Year: 2017 PMID: 28688288 DOI: 10.1016/j.biomaterials.2017.06.038
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479